NO20031387L - O-substituerte 6-metyl-tramadolderivater - Google Patents

O-substituerte 6-metyl-tramadolderivater

Info

Publication number
NO20031387L
NO20031387L NO20031387A NO20031387A NO20031387L NO 20031387 L NO20031387 L NO 20031387L NO 20031387 A NO20031387 A NO 20031387A NO 20031387 A NO20031387 A NO 20031387A NO 20031387 L NO20031387 L NO 20031387L
Authority
NO
Norway
Prior art keywords
substituted
methyl
tramadol derivatives
tramadol
derivatives
Prior art date
Application number
NO20031387A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031387D0 (no
Inventor
Helmut Buschmann
Babette-Yvonne Koegel
Dagmar Kaulartz
Elmar Josef Friderichs
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7658871&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20031387(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of NO20031387D0 publication Critical patent/NO20031387D0/no
Publication of NO20031387L publication Critical patent/NO20031387L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
NO20031387A 2000-09-29 2003-03-26 O-substituerte 6-metyl-tramadolderivater NO20031387L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10049483A DE10049483A1 (de) 2000-09-29 2000-09-29 Substituierte 1-Aminobutan-3-ol-Derivate
PCT/EP2001/011276 WO2002026694A1 (de) 2000-09-29 2001-09-28 O-substituierte 6-methyl-tramadol-derivate

Publications (2)

Publication Number Publication Date
NO20031387D0 NO20031387D0 (no) 2003-03-26
NO20031387L true NO20031387L (no) 2003-05-21

Family

ID=7658871

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20031387A NO20031387L (no) 2000-09-29 2003-03-26 O-substituerte 6-metyl-tramadolderivater
NO20031382A NO20031382L (no) 2000-09-29 2003-03-26 Substituerte 1-aminobutan-3-ol-derivater

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20031382A NO20031382L (no) 2000-09-29 2003-03-26 Substituerte 1-aminobutan-3-ol-derivater

Country Status (29)

Country Link
US (2) US7022739B2 (es)
EP (2) EP1322593B1 (es)
JP (2) JP2004509939A (es)
KR (2) KR100864796B1 (es)
CN (2) CN100391933C (es)
AR (1) AR034158A1 (es)
AT (2) ATE272046T1 (es)
AU (4) AU2057802A (es)
BR (2) BR0114380A (es)
CA (2) CA2423860A1 (es)
DE (3) DE10049483A1 (es)
DK (2) DK1322592T4 (es)
EC (2) ECSP034532A (es)
ES (2) ES2225628T3 (es)
HK (2) HK1052924B (es)
HU (2) HUP0303195A3 (es)
IL (2) IL155106A0 (es)
MX (2) MXPA03002737A (es)
NO (2) NO20031387L (es)
NZ (2) NZ524976A (es)
PE (1) PE20020413A1 (es)
PL (2) PL361632A1 (es)
PT (2) PT1322592E (es)
RU (2) RU2286334C2 (es)
SI (2) SI1322592T1 (es)
SK (2) SK3382003A3 (es)
TR (2) TR200402030T4 (es)
WO (2) WO2002028817A1 (es)
ZA (2) ZA200303214B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
DE60213116T2 (de) 2001-10-16 2007-02-08 Endo Pharmaceuticals Inc. Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
IL162874A0 (en) * 2002-01-11 2005-11-20 Sankyo Co Amino alcohol and phosphonic acid derivatives and pharmaceutical compositions containing the same
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
DK1562567T3 (en) * 2002-11-22 2017-07-17 Gruenenthal Gmbh Combination of selected analgesics with COX II inhibitors
AU2005215320B2 (en) 2004-02-24 2008-04-17 Sankyo Company, Limited Amino alcohol compound
KR101581289B1 (ko) * 2007-05-31 2015-12-31 세프라코 아이엔시. 모노아민 재흡수 억제제로서 페닐 치환된 시클로알킬아민
AU2009322158A1 (en) * 2008-12-05 2010-06-10 Arqule, Inc. RAF inhibitors and their uses
ES2343050B1 (es) * 2008-12-16 2011-06-14 Chemo Iberica, S.A. Procedimiento para la preparacion de desvenlafaxina y sus sales de adicion de acido farmaceuticamente aceptables.
WO2012100423A1 (en) * 2011-01-27 2012-08-02 Eli Lilly And Company Analgesic compounds, methods, and formulations
WO2017125351A1 (en) * 2016-01-21 2017-07-27 Laboratorios Lesvi Sl Process for preparing (( r)-3-[(-1-methylpyrrolidin-2-yl)methyl]-5-(2-phenylsulfonylethyl)-1h-indole

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
ZA732238B (en) * 1972-04-06 1974-01-30 American Home Prod Benzylamine analgesics
US4155935A (en) * 1973-03-26 1979-05-22 American Home Products Corporation Benzylamine analgesics
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
US6017963A (en) * 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
DE19547766A1 (de) 1995-12-20 1997-06-26 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe
DE19601744C2 (de) * 1996-01-19 1998-04-16 Gruenenthal Gmbh Verfahren zur Herstellung der Enantiomeren von O-Demethyltramadol
DE19609847A1 (de) † 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
US5919826A (en) * 1996-10-24 1999-07-06 Algos Pharmaceutical Corporation Method of alleviating pain
US6245804B1 (en) * 1997-05-30 2001-06-12 Schering Aktiengesellschaft Nonsteroidal gestagens
AU730530B2 (en) * 1997-07-15 2001-03-08 Russinsky Limited Tramadol, salts thereof and process for their preparation
DE69913955T2 (de) * 1998-05-22 2004-12-16 Mallinckrodt, Inc. Ein verbessertes synthese- und reinigungsverfahren für (r*,r*)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl) cyclohexanol hydrochlorid
ES2141688B1 (es) * 1998-11-06 2001-02-01 Vita Invest Sa Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
DE19915601A1 (de) * 1999-04-07 2000-10-19 Gruenenthal Gmbh 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
NZ517106A (en) * 1999-08-20 2005-04-29 Ortho Mcneil Pharm Inc Composition comprising a tramadol material and an anticonvulsant drug
PE20010623A1 (es) * 1999-10-05 2001-07-07 Gruenenthal Chemie Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
US6339105B1 (en) * 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
DE10000312A1 (de) * 2000-01-05 2001-07-12 Gruenenthal Gmbh Substituierte Aminomethyl-Phenyl-Cyclohexanderivate
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
DE10048714A1 (de) * 2000-09-30 2002-04-11 Gruenenthal Gmbh 5-Amino-1-penlen-3-ol-Derivate
US6649783B2 (en) * 2001-10-03 2003-11-18 Euro-Celtique, S.A. Synthesis of (+/-)-2-((dimethylamino)methyl)-1-(aryl)cyclohexanols
US6780891B2 (en) * 2001-11-30 2004-08-24 Sepracor Inc. Tramadol analogs and uses thereof

Also Published As

Publication number Publication date
HUP0303195A3 (en) 2007-03-28
CN100391933C (zh) 2008-06-04
BR0114380A (pt) 2003-12-30
EP1322592A1 (de) 2003-07-02
ECSP034530A (es) 2003-05-26
DE50103036D1 (de) 2004-09-02
CN1478067A (zh) 2004-02-25
PT1322592E (pt) 2004-12-31
AU2002220578B2 (en) 2006-11-30
CA2423903A1 (en) 2003-03-27
PL361382A1 (en) 2004-10-04
EP1322593A1 (de) 2003-07-02
SK286727B6 (sk) 2009-04-06
ZA200303220B (en) 2004-08-19
BR0114381A (pt) 2003-12-30
ECSP034532A (es) 2003-05-26
CN1466567A (zh) 2004-01-07
KR100835549B1 (ko) 2008-06-09
RU2288219C2 (ru) 2006-11-27
SK3402003A3 (en) 2003-09-11
NO20031382D0 (no) 2003-03-26
HK1052925B (zh) 2005-04-01
DK1322592T4 (da) 2009-10-12
HK1052924B (zh) 2005-03-24
HK1052925A1 (en) 2003-10-03
ES2225628T3 (es) 2005-03-16
NZ524976A (en) 2005-01-28
JP2004510755A (ja) 2004-04-08
AU2001289937B2 (en) 2007-01-18
PT1322593E (pt) 2004-12-31
AR034158A1 (es) 2004-02-04
KR20030077531A (ko) 2003-10-01
DK1322592T3 (da) 2004-11-22
ES2225605T3 (es) 2005-03-16
ES2225605T5 (es) 2009-11-18
AU2057802A (en) 2002-04-08
US6828345B2 (en) 2004-12-07
KR20030059160A (ko) 2003-07-07
HUP0303361A3 (en) 2007-03-28
EP1322592B1 (de) 2004-07-28
ZA200303214B (en) 2004-08-31
AU8993701A (en) 2002-04-15
WO2002026694A1 (de) 2002-04-04
US7022739B2 (en) 2006-04-04
TR200402030T4 (tr) 2004-09-21
DK1322593T3 (da) 2004-10-11
RU2286334C2 (ru) 2006-10-27
DE50103035D1 (de) 2004-09-02
MXPA03002737A (es) 2004-01-26
NO20031382L (no) 2003-05-16
ATE272046T1 (de) 2004-08-15
TR200402230T4 (tr) 2004-10-21
IL155106A0 (en) 2003-10-31
JP2004509939A (ja) 2004-04-02
WO2002028817A1 (de) 2002-04-11
ATE272045T1 (de) 2004-08-15
US20030216393A1 (en) 2003-11-20
NO20031387D0 (no) 2003-03-26
PL361632A1 (en) 2004-10-04
EP1322593B1 (de) 2004-07-28
SI1322593T1 (en) 2004-12-31
HUP0303195A2 (hu) 2003-12-29
MXPA03002738A (es) 2004-01-26
CA2423860A1 (en) 2003-03-27
HK1052924A1 (en) 2003-10-03
SK3382003A3 (en) 2003-08-05
SI1322592T1 (en) 2005-02-28
NZ525171A (en) 2006-02-24
KR100864796B1 (ko) 2008-10-23
IL155105A0 (en) 2003-10-31
DE10049483A1 (de) 2002-05-02
PE20020413A1 (es) 2002-05-18
HUP0303361A2 (hu) 2004-03-01
US20030220389A1 (en) 2003-11-27
EP1322592B2 (de) 2009-06-17

Similar Documents

Publication Publication Date Title
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
DK1226127T3 (da) Substituerede phenylsulfamoylcarboxamider
ATE288437T1 (de) Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
ATE307121T1 (de) Substituierte arylpyrazine
DK1280809T3 (da) Antitumorecteinascidinderivater
NO20025590L (no) Fenylglycin-derivater
ATE298332T1 (de) Decahydro-isochinolinderivate
ATE414056T1 (de) Substituierte c-cyclohexylmethylamin-derivative
ATE365721T1 (de) Substituierte benzoylcyclohexenone
DE50103036D1 (de) O-substituierte 6-methyl-tramadol-derivate
ATE282021T1 (de) Substituierte aminomethyl-phenyl- cyclohexanderivate
AR028302A1 (es) Feniluracilos substituidos
ATE280752T1 (de) Aminomethyl-phenyl-cyclohexanonderivate
DK1322590T3 (da) Substituerede 5-amino-1-penten-3-ol-derivater
ATE374776T1 (de) Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no) 2-fenylpyran-4-on-derivater
DK1246793T3 (da) Substituerede aminomethyl-phenyl-cyclohexanderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application